Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Parkinson's disease and the Stroop color word test: processing speed and interference algorithms.
Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
Identification of Ser-Pro-Cys-Peptide in Blood Serum of Multiple Sclerosis Patients.
Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin.
Web-based interventions in multiple sclerosis: the potential of tele-rehabilitation.
Proteolytic processing of Neuregulin-1.
Structural brain indices and executive functioning in multiple sclerosis: A review.
Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells.
Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust.
Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.
Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran.
Treatment for Krabbe's disease: Finding the combination.
New oral drugs for the treatment of multiple sclerosis.
Oligodendrocytes: Functioning in a Delicate Balance Between High Metabolic Requirements and Oxidative Damage.
Epidemiology of Multiple Sclerosis.
Benefits from an autobiographical memory facilitation programme in relapsing-remitting multiple sclerosis patients: a clinical and neuroimaging study.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
The Dual-specificity phosphatase Dusp15 is regulated by Sox10 and Myrf in Myelinating Oligodendrocytes.

Pages